Showing 40,161 - 40,180 results of 133,179 for search '(( a d decrease ) OR ( 5 ((point decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.76s Refine Results
  1. 40161
  2. 40162

    Supplementary Material for: Effect on kidney function recovery guiding decongestion with VExUS in patients with cardiorenal syndrome 1, a randomized control trial by IslasRodríguez J.P. (17587536)

    Published 2023
    “…However, VExUS improved more than twice the odds to achieve decongestion (OR 2.6, 95% CI 1.9-3.0, p=0.01) and the odds to reach a decrease of BNP >30% (OR 2.4; 95% CI 1.3-4.1, p = 0.01). …”
  3. 40163

    The effect of guar gum consumption on the lipid profile in type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials by Jilin Li (8213427)

    Published 2023
    “…The subgroup analysis based on the dosage (g/day) of this compound revealed that ≥20 g/day of guar gum led to a notable decrease in triglyceride (TG) levels (WMD: −12.55 mg/dL, 95% CI: −23.72, −1.37, P = 0.02) versus < 20 g/day (WMD: −1.84 mg/dL, 95% CI: −32.18, 28.49, P = 0.90). …”
  4. 40164

    The capacity to neutralize free viruses prior to completion of CD4 attachment varies across bnAb classes. by Lucia Reh (546554)

    Published 2015
    “…<p><b>A:</b> Schematic of free virus infection of A3.01-CCR5 target cells to measure total and pre-attachment activity of bnAbs. …”
  5. 40165
  6. 40166

    Distribution of NGS reads to the reference sequences (100 kb-bin size) on chromosome 3, 4 and 5 for four M1 mutant sectors [5–3 (blue squares), 13–2 (gray triangles), 15–4 (golden... by Satoshi Kitamura (3226803)

    Published 2022
    “…In addition to the large deletions found by the mutation-calling algorithms (indicated by solid arrows), four additional regions (dotted arrows) showed decrease of the reads. For the regions of chromosome 5 in 5–3 (blue dotted arrow) and chromosome 3 in 15–4 (golden dotted arrow), probable junctions could not be detected from our NGS data (labeled as “undetermined”). …”
  7. 40167

    Neutralizing antibodies and cellular immune response after two doses of inactivated SARS-CoV-2 vaccine in China by Li-Na Yan (10957512)

    Published 2022
    “…</p> <p>A majority of the vaccinated (>90%) developed robust NAbs and T-cell responses to SARS-CoV-2 in the first two months after the second dose. …”
  8. 40168
  9. 40169
  10. 40170
  11. 40171
  12. 40172
  13. 40173
  14. 40174
  15. 40175
  16. 40176

    Synthesis and Biological Evaluation of Heterocyclic Ring-Fused 20(<i>S</i>)‑Protopanaxadiol Derivatives as Potent Antiosteoporosis Agents by Shuan-Jing Wang (16854232)

    Published 2023
    “…Mechanistic studies revealed that SH491 inhibits the expression of osteoclastogenesis-related marker genes and proteins, including TRAP, CTSK, MMP-9, and ATPase v0d2. <i>In vivo</i>, SH491 could dramatically decrease the ovariectomy-induced osteoclast activity and relieve osteoporosis obviously. …”
  17. 40177

    Capacity of Broadly Neutralizing Antibodies to Inhibit HIV-1 Cell-Cell Transmission Is Strain- and Epitope-Dependent by Lucia Reh (546554)

    Published 2015
    “…Pre-CD4 attachment activity proved strongest amongst CD4bs bnAbs and varied substantially for V3 and V1V2 loop bnAbs in a strain-dependent manner. …”
  18. 40178

    Image_1_Epidemiological characteristics of Omicron and Delta SARS-CoV-2 variant infection in Santiago, Chile.pdf by Andrea Mella-Torres (12978488)

    Published 2022
    “…This report is framed at the beginning of Chile's third wave of the COVID-19 pandemic, with a marked increase in the Omicron variant and a decrease in the circulating Delta variant. …”
  19. 40179

    Densities of retinal ganglion cells (RGCs) labeled with 5% FluoroGold 8 weeks after the induction of elevated IOP. by Verena Prokosch (316871)

    Published 2013
    “…<b>B</b> RGCs in an untreated retina with elevated IOP without hypotensive treatment. <b>C</b> RGCs in a retina with elevated IOP treated with 0.5% timolol (Ti) and travoprost (Ti/Tr) for 4 weeks [the results were the same for those treated with 0.5% Ti and dorzolamide (Ti/D), and 0.5% Ti and brimonidine (Ti/B)]. …”
  20. 40180